Article
p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
PloS one - 1 Jan 2014
Novello Chiara, Pazzaglia Laura, Conti Amalia, Quattrini Irene, Pollino Serena, Perego Paola, Picci Piero, Benassi Maria Serena
Abstract excerpt
Osteosarcoma (OS) is the most common primary malignant bone tumor and prevalently occurs in the second decade of life. Etoposide, a chemotherapeutic agent used in combined treatments of recurrent human OS, belongs to the topoisomerase inhibitor family and causes DNA breakage. In this study we evaluated the cascade of events determined by etoposide-induced DNA damage in OS cell lines with different p53 status...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
